|
|
|
Insider
Information: |
Van Der Ploeg Leonardus H.t. |
Relationship: |
Chief Scientific Officer |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
42,339 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,212,213 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
42,339 |
|
|
Total
Value |
$2,212,213 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
Chief Scientific Officer |
2019-05-31 |
42,339 |
2018-06-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2019-01-16 |
4 |
AS |
$30.00 |
$6,000 |
D/D |
(200) |
42,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2018-06-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
62,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2019-05-29 |
4 |
S |
$25.51 |
$127,550 |
D/D |
(5,000) |
42,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2019-05-29 |
4 |
OE |
$4.59 |
$22,950 |
D/D |
5,000 |
47,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2019-05-30 |
4 |
S |
$25.31 |
$126,550 |
D/D |
(5,000) |
42,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2019-05-30 |
4 |
OE |
$4.59 |
$22,950 |
D/D |
5,000 |
47,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2019-05-31 |
4 |
OE |
$4.59 |
$22,950 |
D/D |
5,000 |
47,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2019-05-31 |
4 |
S |
$25.10 |
$125,500 |
D/D |
(5,000) |
42,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2019-05-28 |
4 |
OE |
$4.59 |
$46,117 |
D/D |
10,000 |
52,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2019-05-28 |
4 |
S |
$25.38 |
$253,800 |
D/D |
(10,000) |
42,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2018-09-25 |
4 |
OE |
$4.59 |
$100,062 |
D/D |
21,800 |
84,139 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2018-11-02 |
4 |
OE |
$4.59 |
$174,238 |
D/D |
28,200 |
80,539 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2018-09-25 |
4 |
AS |
$27.45 |
$947,540 |
D/D |
(31,800) |
52,339 |
0 |
- |
|
RYTM |
Rhythm Pharmaceuticals, I... |
Chief Scientific Officer |
|
2018-11-02 |
4 |
AS |
$30.09 |
$1,143,420 |
D/D |
(38,000) |
42,539 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|